tradingkey.logo

OptimizeRx Corp

OPRX
View Detailed Chart

18.920USD

+1.140+6.41%
Close 09/18, 16:00ETQuotes delayed by 15 min
351.08MMarket Cap
LossP/E TTM

OptimizeRx Corp

18.920

+1.140+6.41%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.41%

5 Days

+0.48%

1 Month

+11.43%

6 Months

+109.76%

Year to Date

+289.30%

1 Year

+146.35%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-18

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
78 / 470
Overall Ranking
141 / 4721
Industry
Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 7 analysts
Buy
Current Rating
19.000
Target Price
+6.86%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 47.52% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 92.13M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 75.81.
Undervalued
The company’s latest PE is -35.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 14.95M shares, decreasing 32.91% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 920.88K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.89.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Ticker SymbolOPRX
CompanyOptimizeRx Corp
CEOMr. Stephen L. (Steve) Silvestro
Websitehttps://www.optimizerx.com/
KeyAI